Eunbin Park

Eunbin Park

Auto-generated profile, based on publicly available information

Eunbin Park

Center for Neuroscience Research, Children's National Hospital, Washington, DC 20010

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2025 in Journal of Neuroscience
Verified
Journal Article
Open access
ZAZeynep Atak
Zeynep Atak
ASAnup Srivastava
Anup Srivastava
SGSachin Gandhi
Sachin Gandhi
EPEunbin Park
Eunbin Park
JWJonathan Williams
Jonathan Williams
THTarik F. Haydar
Tarik F. Haydar
Cognitive, social behavior, speech, and motor skills are known challenges for people with trisomy 21/Down syndrome (DS), but the precise mechanisms that lead to these impactful changes have not yet been described. Data from human and mouse model fetal brains indicate that alterations in prenatal neurogenesis might account for the neurological phenotypes that manifest after birth. Here, we evaluated key features of cortical neurogenesis in the humanized mouse model of DS (TcMAC21 of undetermined sex) to test whether and how the presence of the human HSA21q transchromosome impacts cortical development. Brain growth measurements throughout the second half of gestation and at several periods of postnatal development show overall that the TcMAC21 brain phenotype is less severe than in other DS mouse models that have less genetic similarity to humans with DS. However, despite the lack of gross changes in brain growth, we uncovered a significant temporally limited neurogenesis defect at midgestation that correlates with long-lasting effects on neuronal dispersion and neuronal function in the neocortex. Using Cre/Lox-mediated genetic fate mapping, we discovered a transient reduction in neocortical basal intermediate progenitor cells (bIPCs) and that bIPC neuronal progeny are underrepresented in the superficial layers of the neocortex. This change in neuronal production is associated with cortical activity changes after birth. Altogether, our data isolate the cell types associated with a very specific temporal change in cortical formation that, due to the high levels of excitability of bIPC-derived neurons, creates lasting effects on network activity and circuit development in trisomic brains.

25 February 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
AHAllison Horvath
Allison Horvath
CAClara M. Abdelmalek
Clara M. Abdelmalek
EPEunbin Park
Eunbin Park
AAAubrey P. Alexander
Aubrey P. Alexander
SMSadhana A. Maheswaran
Sadhana A. Maheswaran
YKYoussef A. Kousa
Youssef A. Kousa
Zika, a mosquito-borne flavivirus, has been found in 87 countries and territories. Global outbreaks peaked in 2016. Prenatal infection of Zika virus was found to be associated with microcephaly, arthrogryposis, intracranial calcifications, fetal growth restriction, and fetal demise. The most severely affected children were diagnosed with congenital Zika syndrome, which impacts thousands worldwide. With no approved treatment or preventative measures for Zika, future viral outbreaks have the potential to cause epidemic levels of prenatal brain injury, as seen over the past 70 years. Therefore, there is a great need for a reliable and clinically translational experimental system that mimics the human condition of prenatal Zika infection. To this end, we developed a humanized, immunocompetent mouse model system of virally induced brain injury from prenatal Zika infection, which ranges from mild to severe. Here, we describe the extent to which this system mirrors the human phenotypic spectrum. Using our thorough preclinical system, we find that prenatal Zika infection of mice impacts survival rate, anthropometric measurements, tissue formation, and neurological outcomes, all of which are typical of prenatal infection. Single-cell RNA sequencing of the Zika-infected cerebral cortex reveals severely disrupted transcriptome profiles and suggests that these injuries are a result of a depletion of neural stem cells. Current and future applications include the identification of genetic or environmental modifiers of brain injury, molecular or mechanistic studies of pathogenesis, and preclinical evaluation of future therapies.